Related content

Bayesian Approach to Estimate AUC, Partition Coefficient and Drug Targeting Index for Studies with Serial Sacrifice Design

By Wang Tianli   Baron Kyle   Zhong Wei   Brundage Richard   Elmquist William  

Pharmaceutical Research, Vol. 31, Iss. 3, 2014-03 ,pp. : 649-659

Springer Publishing Company

Access to resources Recommend Favorite

A Tolerance Interval Approach for Assessment of Agreement with Left Censored Data

By Choudhary Pankaj K.  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 4, 2007-07 ,pp. : 583-594

Taylor & Francis Ltd

Access to resources Recommend Favorite

AUC AND cmax ARE NOT SUFFICIENT TO PROVE BIOEQUIVALENCE

By Rescigno A.   Powers J.D.  

Pharmacological Research, Vol. 37, Iss. 2, 1998-02 ,pp. : 93-95

Academic Press

Access to resources Recommend Favorite

Noninferiority Tests Based on Concordance Correlation Coefficient for Assessment of the Agreement for Gene Expression Data from Microarray Experiments

By Liao Chen-Tuo  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 2, 2007-03 ,pp. : 309-327

Taylor & Francis Ltd

Access to resources Recommend Favorite

Benefit–risk assessment: the use of clinical utility index

By Ouellet Daniele  

Expert Opinion on Drug Safety, Vol. 9, Iss. 2, 2010-03 ,pp. : 289-300

Informa Healthcare

Access to resources Recommend Favorite